Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo

Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

(2010) X. Zheng et al.   Cancer Prevention Research

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

(2009) A. Fontana et al.   CLINICAL CANCER RESEARCH

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers

(2009) Emmanuel S. Antonarakis et al.   JOURNAL OF CLINICAL ONCOLOGY

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

(2009) R. E. Harris   INFLAMMOPHARMACOLOGY

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial

(2008) Nicholas D. James et al.   BJU INTERNATIONAL

Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation

(2008) Wenyan Lu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inflammation and Prostate Cancer: A Future Target for Prevention and Therapy?

(2007) David Stock et al.   UROLOGIC CLINICS OF NORTH AMERICA